In two posts, Devex’s “Impact” blog examines the role of the private sector in global health initiatives. In one post, “Impact” interviews Ariel Pablos-Méndez, assistant administrator for global health at USAID. According to the interview transcript, Pablos-Méndez discusses “the benefits of public-private partnerships,” highlights “USAID’s efforts to promote girls and women’s health,” and examines “what financing models are the most sustainable and why,” in addition to other topics (4/16). In a separate post, Devex analyst Christine Dugay examines private sector support for global health and presents “an analysis of two major global industries, which are perhaps more involved in social development than any others: pharmaceuticals and oil.” She continues, “Here, Devex assesses the 2011 financial commitments, strategies and programs of three leading pharmaceutical companies — Pfizer, Merck and GlaxoSmithKline PLC — and three major oil companies — Exxon Mobil Corp., Chevron and Royal Dutch Shell PLC — all of which are positioning themselves as private sector philanthropic leaders through social investment and global health spending” (4/15).